Results 101 to 110 of about 37,549 (151)

Multidrug-resistant tuberculosis (MDR-TB): an evolving threat to the Nigerian health system - a review. [PDF]

Ann Med Surg (Lond)
Shehu A, Oduoye MO, Siddiqui AN, Shaikh H, Odhiambo J, Muhsin M, Zubairu AZ, Ezenwoba C, Abdulhadi A, Biamba C, Shakeel L, Alhassan A, Karegeya A, Mugisha MJM, Wei CR, Zihindula F, Ndagano EB, Ntumba TN, Tague C, Akilimali A.   +19 more
europepmc   +1 more source

Adverse Drug Reaction to Linezolid in Drug-Resistant Tuberculosis: A Systematic Review. [PDF]

Med Sci (Basel)
Oktaviani E, Anggadiredja K, Amalia L.
europepmc   +1 more source

Tracking the evolution of an extensively drug-resistant cross-border <i>Mycobacterium tuberculosis</i> cluster, Europe, January 2016 up to August 2025: implications for European surveillance. [PDF]

Euro Surveill
Saluzzo F, Sepulcri C, Zinola A, Di Marco F, Ragazzoni L, Rossi M, Codecasa L, Cirillo DM.   +7 more
europepmc   +1 more source

Key resistance-associated mutations in multidrug-resistant tuberculosis: a genomic study from Shanghai, China, with a focus on aminoglycosides. [PDF]

BMC Microbiol
Guo Y, Yang J, Wang H, Sha W, Yu F.
europepmc   +1 more source

Educational Level Mediates the Relationship Between Knowledge and Preventive Practices in Multidrug-Resistant Tuberculosis Patients. [PDF]

Epidemiologia (Basel)
Guardia Zuñiga RC, Abad de Vite BV, Azañero Suarez A, Espino Carrasco DK, García Santos E, Lajo Aquise IE, Cachay Sánchez I.   +6 more
europepmc   +1 more source

Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022-2024. [PDF]

Open Forum Infect Dis
Liang R, Brust JCM, Reed C, Escuyer V, Armstrong DT, Parrish N, Valois P, Rowlinson MC, Marinova-Petkova A, Bisson GP, Labuda SM, Colon-Semidey A, Haley CA, Ashkin D, Peloquin CA, Lardizabal A, Patrawalla A, Cuenca A, Haas MK, Brostrom R, Mbakwem C, Schechter MC, Ray SM, Cummins J, Cahill B, Arn K, Chen LL, Wilson JW, Goswami ND.   +28 more
europepmc   +1 more source

Time trend prediction of multidrug-resistant/rifampicin-resistant tuberculosis in treatment initiation centers of North East Ethiopia (2015-2023). [PDF]

BMC Infect Dis
Abegaz EA, Mesfin MA, Bazie GW.
europepmc   +1 more source

Plasma and CSF pharmacokinetic characteristics of second-line anti-tuberculosis drugs in a patient with multidrug-resistant tuberculous meningitis. [PDF]

BMC Infect Dis
Gao J, Cao J, Li J, Pan X, Wang H, Cai X, Chen Y.   +6 more
europepmc   +1 more source

Time to sputum culture conversion and associated factors in multidrug-resistant tuberculosis patients in Southwestern Oromia, Ethiopia: a ten-year retrospective follow-up study. [PDF]

BMC Pulm Med
Balay G, Bonsa Z, Bekele E, Abeba G, Solomon E, Tadesse M, Kebede W, Abebe G.   +7 more
europepmc   +1 more source

Drug resistance patterns among tuberculosis patients at a tuberculosis designated hospital in Yunnan: a retrospective analysis of the 2013-2022 period. [PDF]

BMC Infect Dis
Dai J, Li Q, Chen J, Zhang P, Zhao J, Liu Y, Chongsuvivatwong V.   +6 more
europepmc   +1 more source